Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Retinitis Pigmentosa (RP) Clinical Trials

6 recruiting trials for Retinitis Pigmentosa (RP). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT06787482

Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

Summary of the Study This clinical trial evaluates a novel peptide-based therapy for treating retinal dystrophies, age-related macular degeneration (AMD), and diabetic retinopathy...

Sponsor: Ace Cells Lab LimitedEnrolling: 1002 locations
RECRUITINGNCT07126470

Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients

This is a self-controlled randomized clinical trial to investigate the effect of capsular tension ring (CTR) implantation on intraocular lens (IOL) position in cataract patients...

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityEnrolling: 881 location
RECRUITINGNCT07292987

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional...

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsEnrolling: 801 location
RECRUITINGPhase 1 / Phase 2NCT06789445

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 in...

Sponsor: BlueRock TherapeuticsEnrolling: 543 locations
RECRUITINGPhase 2NCT06627179

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa...

Sponsor: Laboratoires TheaEnrolling: 8120 locations
RECRUITINGNCT07266584

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

The objective of this study is to evaluate the efficacy and safety of the PRIMA Products in participants with inherited retinal degeneration affecting the macula (including but...

Sponsor: Science CorporationEnrolling: 51 location